We are live on ! Find out more
FGP

Foyston, Gordon, & Payne Portfolio holdings

AUM $434M
1-Year Est. Return 9.09%
This Fund
S&P 500
This Quarter Est. Return
+10.55%
1 Year Est. Return
+9.09%
3 Year Est. Return
+56.86%
5 Year Est. Return
+84.63%
10 Year Est. Return
+238.52%
AUM
$401M
AUM Growth
-$4.94M
Cap. Flow
-$42.5M
Cap. Flow %
-10.6%
Top 10 Hldgs %
47.98%
Holding
57
New
2
Increased
14
Reduced
26
Closed
4

Top Buys

Rank Stock Value
1
ICLR icon
Icon
ICLR
+$12.8M
2
WEX icon
WEX
WEX
+$3.27M
3
SEIC icon
SEI Investments
SEIC
+$2.63M
4
CDW icon
CDW
CDW
+$857K
5
ALLE icon
Allegion
ALLE
+$630K

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$14.8M
2
JNJ icon
Johnson & Johnson
JNJ
+$4.56M
3
CSCO icon
Cisco
CSCO
+$3.72M
4
TFC icon
Truist Financial
TFC
+$3.19M
5
KVUE icon
Kenvue
KVUE
+$2.9M

Sector Composition

Rank Sector Weight
1 Technology 27.13%
2 Healthcare 16.34%
3 Financials 14.48%
4 Consumer Staples 12.02%
5 Consumer Discretionary 11.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SNY icon
51
Sanofi
SNY
$103B
$333K 0.08%
5,784
-24,228
-81% -$1.31M
NSP icon
52
Insperity
NSP
$2.05B
$262K 0.07%
2,973
SKX
53
DELISTED
Skechers
SKX
$207K 0.05%
+3,100
New +$203K
MDT icon
54
Medtronic
MDT
$111B
-187,632
Closed -$14.8M
PEP icon
55
PepsiCo
PEP
$191B
-8,816
Closed -$1.45M
SPNS
56
DELISTED
Sapiens International
SPNS
-7,317
Closed -$248K
UL icon
57
Unilever
UL
$137B
-15,880
Closed -$982K

Similar funds

Foyston, Gordon, & Payne's Q3 2024 Portfolio in Review

As of Q3 2024, Foyston, Gordon, & Payne held 57 positions worth $401M, down 1.2% from $406M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Foyston, Gordon, & Payne withdrew a net $42.5M in Q3 2024, closing 4 positions and reducing 26 holdings. Its most notable exit was Medtronic, an estimated $14.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Foyston, Gordon, & Payne opened a new position in Icon worth $11.7M.

  • Foyston, Gordon, & Payne's largest Q3 2024 buy was Icon: 40,624 shares worth $11.7M.
  • Foyston, Gordon, & Payne added most to WEX in Q3 2024, an estimated $3.27M increase.
  • Foyston, Gordon, & Payne's biggest Q3 2024 reduction was Johnson & Johnson, cutting an estimated $4.56M.
  • Foyston, Gordon, & Payne fully exited Medtronic in Q3 2024, selling an estimated $14.8M.
  • Foyston, Gordon, & Payne's ten largest holdings make up 48% of its $401M portfolio in Q3 2024.
  • Foyston, Gordon, & Payne opened 2 new positions and closed 4 in Q3 2024.
  • Foyston, Gordon, & Payne's portfolio value fell 1.2% quarter-over-quarter to $401M.

Based on Foyston, Gordon, & Payne's 13F filing for Q3 2024, filed 15 Nov 2024.